175 related articles for article (PubMed ID: 2453712)
21. [Complement system].
Korol' SA
Fiziol Zh; 1977; 23(3):408-16. PubMed ID: 326583
[No Abstract] [Full Text] [Related]
22. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of consumption kinetics of the C4 and C2 components of complement by immune complexes "in vitro" (author's transl)].
Roncato M; Maillet F; Peltier AP
Pathol Biol (Paris); 1981 Feb; 29(2):95-9. PubMed ID: 7015243
[TBL] [Abstract][Full Text] [Related]
24. [Components of human complement system. Testing and isolation of C3 and C5].
Kosiak AV; Shukun SA; Poddubkova TN; Chikh VP; Surovtsev VI
Biokhimiia; 1990 Feb; 55(2):276-84. PubMed ID: 2340315
[TBL] [Abstract][Full Text] [Related]
25. Dual function of insoluble polyanions. Formation of C1 and C42 sites in addition to activation of the alternative pathway of complement.
Burger R; Loos M; Kossorotow A; Hadding U; Bitter-Suermann D
Monogr Allergy; 1977; 12():78-81. PubMed ID: 917023
[No Abstract] [Full Text] [Related]
26. Quantitative determination of complement components produced by purified hepatocytes.
Ramadori G; Rasokat H; Burger R; Meyer Zum Büschenfelde KH; Bitter-Suermann D
Clin Exp Immunol; 1984 Jan; 55(1):189-96. PubMed ID: 6692595
[TBL] [Abstract][Full Text] [Related]
27. Hypochlorite-induced alterations to canine serum complement.
Boyer JT; Wyde P; Bier M
Clin Exp Immunol; 1975 Aug; 21(2):345-50. PubMed ID: 1102168
[TBL] [Abstract][Full Text] [Related]
28. [Activation of the complement system and its components in healthy children aged 4 to 15 years].
Kosenkova TV; Leonova ES; Pialikova GV
Pediatriia; 1990; (7):105. PubMed ID: 2251040
[No Abstract] [Full Text] [Related]
29. The eleventh Hopkins Memorial Lecture: The biochemistry of complement.
Porter RR
Biochem Soc Trans; 1977; 5(6):1659-74. PubMed ID: 340299
[No Abstract] [Full Text] [Related]
30. Prevention of immune precipitation by purified classical pathway complement components.
Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
[TBL] [Abstract][Full Text] [Related]
31. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
32. [Anticomplementary activity of a polyanion: pentosan-poly-sulfoester, II.--Mode of action and "in vitro " inhibition of human complement hemolytic activity (author's transl)].
Berthoux FX; Freyria AM; Traeger J
Pathol Biol (Paris); 1977 Feb; 25(2):105-8. PubMed ID: 322041
[TBL] [Abstract][Full Text] [Related]
33. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
[TBL] [Abstract][Full Text] [Related]
34. [Hereditary complement deficiencies].
Fischer E
Hautarzt; 1982 Feb; 33(2):65-72. PubMed ID: 6281215
[TBL] [Abstract][Full Text] [Related]
35. Purification of the fourth, second and fifth components of mouse complement.
Fukuoka Y; Seino J; Okuda T; Tachibana T
Immunology; 1984 Mar; 51(3):493-501. PubMed ID: 6698577
[TBL] [Abstract][Full Text] [Related]
36. Modulation of lymphocyte proliferative responses to mitogens and antigens by complement components C1, C4 and C2.
Laham MN; Caldwell JR; Panush RS
J Clin Lab Immunol; 1982 Oct; 9(1):39-47. PubMed ID: 6983586
[TBL] [Abstract][Full Text] [Related]
37. Structural homologies of component C5 of human complement with components C3 and C4 by neutron scattering.
Perkins SJ; Smith KF; Nealis AS; Lachmann PJ; Harrison RA
Biochemistry; 1990 Feb; 29(5):175-80. PubMed ID: 2322569
[TBL] [Abstract][Full Text] [Related]
38. Incomplete functional deficiencies of the fourth (C4) and second (C2) components of complement in a patient with linear frontoparietal scleroderma and his family. Deficiencies determined by a gene not linked to human leukocyte antigen system.
Venneker GT; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; de Waall LP; Bos JD; Asghar SS
Exp Clin Immunogenet; 1996; 13(2):104-11. PubMed ID: 9063702
[TBL] [Abstract][Full Text] [Related]
39. [Glomerular localization of the early components of complement in glomerulonephritis].
Barbiano di Belgiojoso G; Tarantino A; Durante A; Guerra L
Minerva Nefrol; 1974; 21(3):169-78. PubMed ID: 4463297
[No Abstract] [Full Text] [Related]
40. Mode of interaction of different polyanions with the first (C1,C1) the second (C2) and the fourth (C4) component of complement. IV. Activation of C1 in serum by polyanions.
Loos M; Bitter-Suermann D
Immunology; 1976 Dec; 31(6):931-4. PubMed ID: 186401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
